Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
14.64
+0.29 (2.05%)
Jan 2, 2025, 11:50 AM EST - Market open
Surrozen Employees
Surrozen had 42 employees as of December 31, 2023. The number of employees decreased by 32 or -43.24% compared to the previous year.
Employees
42
Change (1Y)
-32
Growth (1Y)
-43.24%
Revenue / Employee
$238,095
Profits / Employee
-$1,058,048
Market Cap
47.59M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 42 | -32 | -43.24% |
Dec 31, 2022 | 74 | -9 | -10.84% |
Dec 31, 2021 | 83 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
SRZN News
- 2 months ago - Surrozen to Present at Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 2 months ago - Surrozen Provides Third Quarter 2024 Financial Results and Business Update - GlobeNewsWire
- 2 months ago - Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis - GlobeNewsWire
- 3 months ago - Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration - GlobeNewsWire
- 5 months ago - Surrozen Provides Second Quarter 2024 Financial Results and Business Update - GlobeNewsWire
- 7 months ago - Surrozen Publishes Study in ‘eLife' Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling - GlobeNewsWire
- 7 months ago - Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan - GlobeNewsWire
- 7 months ago - Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis - GlobeNewsWire